UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 670

Sortiert nach

Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles

PloS one, 2011-09, Vol.6 (9), p.e24374

2011

Volltextzugriff (PDF)

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Cell metabolism, 2016-06, Vol.23 (6), p.1127-1139

2016

Volltextzugriff (PDF)

Synchrotron powder diffraction data for some smectite clay mineral standards

Powder diffraction, 2023-09, Vol.38 (3), p.224-230

Reid, Joel W.

2023

Volltextzugriff (PDF)

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

The lancet oncology, 2020-04, Vol.21 (4), p.541-550

2020

Volltextzugriff (PDF)

Pharmacokinetics of Intravitreal Bevacizumab (Avastin)

Ophthalmology (Rochester, MN), 2007-05, Vol.114 (5), p.855-859

2007

Volltextzugriff (PDF)

Controlled Delivery of Vancomycin via Charged Hydrogels

PloS one, 2016-01, Vol.11 (1), p.e0146401

2016

Volltextzugriff (PDF)

Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)

Ophthalmology (Rochester, Minn.), 2007-12, Vol.114 (12), p.2179-2182

2007

Volltextzugriff (PDF)

Powder X-ray diffraction data for dimethylarsinic acid, (CH3)2AsO(OH)

Powder diffraction, 2021-09, Vol.36 (3), p.190-195

Reid, Joel W.

2021

Volltextzugriff (PDF)

Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside

Endocrinology (Philadelphia), 2021-12, Vol.162 (12)

2021

Volltextzugriff (PDF)

Silicon substitution in the calcium phosphate bioceramics

Biomaterials, 2007-10, Vol.28 (28), p.4023-4032

2007

Volltextzugriff (PDF)

Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

European journal of cancer (1990), 2019-11, Vol.121, p.177-183

2019

Volltextzugriff (PDF)

Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits

PloS one, 2020-04, Vol.15 (4), p.e0231841

2020

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

Journal of clinical oncology, 2013-08, Vol.31 (24), p.3034-3043

2013

Volltextzugriff (PDF)

A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)

Clinical cancer research, 2019-06, Vol.25 (11), p.3229-3238

2019

Volltextzugriff (PDF)

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial

Journal of clinical oncology, 2016-04, Vol.34 (12), p.1368-1375

2016

Volltextzugriff (PDF)

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma

Scientific reports, 2023-09, Vol.13 (1), p.14360-14360, Article 14360

2023

Volltextzugriff (PDF)

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-01, Vol.30 (3), p.256-262

2012

Volltextzugriff (PDF)

Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review

Mayo Clinic proceedings, 2019-03, Vol.94 (3), p.500-514

2019

Volltextzugriff (PDF)

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Cancer research (Chicago, Ill.), 2008-03, Vol.68 (6), p.1970-1978

2008

Volltextzugriff (PDF)

Welcoming Gallium- and Indium-Fumarate MOFs to the Family: Synthesis, Comprehensive Characterization, Observation of Porous Hydrophobicity, and CO2 Dynamics

ACS applied materials & interfaces, 2018-08, Vol.10 (34), p.28582-28596

2018

Volltextzugriff (PDF)

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2052-2058

2009

Volltextzugriff (PDF)

Combined local delivery of tacrolimus and stem cells in hydrogel for enhancing peripheral nerve regeneration

Biotechnology and bioengineering, 2021-07, Vol.118 (7), p.2804-2814

2021

Volltextzugriff (PDF)

Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma

Cancer, 2023-07, Vol.129 (14), p.2245-2255

2023

Volltextzugriff (PDF)

Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)

Clinical cancer research, 2020-03, Vol.26 (6), p.1213-1219

2020

Volltextzugriff (PDF)

Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3623-3629

2010

Volltextzugriff (PDF)

1 – 25 von 670

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(627)
Mit Volltextzugriff
(637)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Synchrotron powder diffraction data for some smectite clay mineral standards

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

Pharmacokinetics of Intravitreal Bevacizumab (Avastin)

Controlled Delivery of Vancomycin via Charged Hydrogels

Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)

Powder X-ray diffraction data for dimethylarsinic acid, (CH3)2AsO(OH)

Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside

Silicon substitution in the calcium phosphate bioceramics

Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Welcoming Gallium- and Indium-Fumarate MOFs to the Family: Synthesis, Comprehensive Characterization, Observation of Porous Hydrophobicity, and CO2 Dynamics

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Combined local delivery of tacrolimus and stem cells in hydrogel for enhancing peripheral nerve regeneration

Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma

Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)

Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report

Suchergebnisse filtern